Insider Transactions in Q4 2022 at Amicus Therapeutics, Inc. (FOLD)
Insider Transaction List (Q4 2022)
| Date | Insider | Transaction | Ownership Type | Shares Traded | Value / Price |
|---|---|---|---|---|---|
|
Dec 15
2022
|
John F Crowley Executive Chairman |
SELL
Open market or private sale
|
Direct |
10,468
-1.31%
|
$125,616
$12.15 P/Share
|
|
Dec 01
2022
|
Bradley L Campbell President and CEO |
SELL
Open market or private sale
|
Direct |
5,485
-0.79%
|
$65,820
$12.2 P/Share
|
|
Dec 01
2022
|
Bradley L Campbell President and CEO |
BUY
Exercise of conversion of derivative security
|
Direct |
5,485
+0.78%
|
$16,455
$3.53 P/Share
|
|
Dec 01
2022
|
John F Crowley Executive Chairman |
SELL
Open market or private sale
|
Direct |
11,347
-1.4%
|
$136,164
$12.2 P/Share
|
|
Nov 15
2022
|
John F Crowley Executive Chairman |
SELL
Open market or private sale
|
Direct |
10,468
-1.27%
|
$115,148
$11.64 P/Share
|
|
Nov 01
2022
|
Bradley L Campbell President and CEO |
SELL
Open market or private sale
|
Direct |
5,470
-0.79%
|
$54,700
$10.01 P/Share
|
|
Nov 01
2022
|
Bradley L Campbell President and CEO |
BUY
Exercise of conversion of derivative security
|
Direct |
5,470
+0.78%
|
$16,410
$3.53 P/Share
|
|
Nov 01
2022
|
John F Crowley Executive Chairman |
SELL
Open market or private sale
|
Direct |
11,346
-1.36%
|
$113,460
$10.32 P/Share
|
|
Oct 17
2022
|
John F Crowley Executive Chairman |
SELL
Open market or private sale
|
Direct |
10,468
-1.24%
|
$104,680
$10.9 P/Share
|
|
Oct 09
2022
|
David Michael Clark Chief People Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
5,510
-2.56%
|
$55,100
$10.4 P/Share
|
|
Oct 03
2022
|
John F Crowley Executive Chairman |
SELL
Open market or private sale
|
Direct |
11,346
-1.32%
|
$113,460
$10.75 P/Share
|
|
Oct 03
2022
|
Bradley L Campbell President and CEO |
SELL
Open market or private sale
|
Direct |
5,470
-0.79%
|
$54,700
$10.53 P/Share
|
|
Oct 03
2022
|
Bradley L Campbell President and CEO |
BUY
Exercise of conversion of derivative security
|
Direct |
5,470
+0.78%
|
$16,410
$3.53 P/Share
|